Question to the Department of Health and Social Care:

To ask the Secretary of State for Health and Social Care, when he plans to answer Question 287932 on Hormone Replacement Therapy tabled on 19 September 2019 by the Hon. member for Birmingham Edgbaston; and if he will make a statement.

We are aware that the Evorel Transdermal Patch range has been unavailable from November 2019 due to a change in ownership of the product range from Janssen-Cilag to Theramex. The Department has been in regular contact with Theramex, who began reintroduction of Evorel Conti and Evorel 50 patches from mid- February 2020, with further supplies expected at the end of this month. The whole Evorel range is expected to be available by the end of March 2020.

Although the supply of Evorel patches has been affected, alternative hormone replacement therapy products continue to remain available. We regularly update the National Health Service on the supply situation and are continuing to engage with organisations such as the Royal College of Obstetricians and Gynaecologists, the Faculty of Sexual and Reproductive Healthcare and the British Menopausal Society.